Scribe Therapeutics Stock Forecast

Hold candidate since Jul 23, 2026 Gain 66.20%

The Scribe Therapeutics Inc. stock price fell by -4.12% on the last day (Monday, 10th Aug 2026) from $26.00 to $24.93. During the last trading day the stock fluctuated 9.94% from a day low at $23.85 to a day high of $26.22. The price has risen in 7 of the last 10 days and is up by 31.42% over the past 2 weeks. Volume has increased on the last day by 30 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 150 thousand shares were bought and sold for approximately $3.74 million.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $23.84 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 41.64% during the next 3 months and, with a 90% probability hold a price between $33.76 and $41.98 at the end of this 3-month period.

SCTX Signals & Forecast

The Scribe Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $23.22 and $21.15. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, August 07, 2026, and so far it has fallen -4.12%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Scribe Therapeutics Inc. stock

Scribe Therapeutics Inc. finds support from accumulated volume at $23.80 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $2.37 between high and low, or 9.94%. For the last week the stock has had daily average volatility of 11.90%.

Our recommended stop-loss: $23.91 (-4.08%) (This stock has very low daily movements and this gives very low risk. The RSI14 is 74 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (SCTX) For The Upcoming Trading Day Of Tuesday 11th

Since the stock is closer to the resistance from accumulated volume at $25.41 (1.93%) than the support at $23.80 (4.53%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Scribe Therapeutics Inc. stock A Buy?

Scribe Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $25.00 ( 0.282%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk